12:00 AM
 | 
Jan 16, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Epanova endocrine/metabolic data

Data from a pharmacokinetic trial in 52 subjects on a low-fat diet showed that Epanova produced plasma levels of EPA and DHA that were 5.8 times higher at day 14 after dosing vs. Lovaza omega-3-acid ethyl esters. Epanova...

Read the full 179 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >